SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049247
Filing Date
2024-04-26
Accepted
2024-04-26 16:44:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A trvi-2024-defa14a.htm DEFA14A 25710
2 GRAPHIC img176840433_0.jpg GRAPHIC 229190
3 GRAPHIC img176840433_1.jpg GRAPHIC 130369
  Complete submission text file 0000950170-24-049247.txt   521805
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38886 | Film No.: 24884641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)